Derma Sciences, Inc. (Derma Sciences), is a medical technology company focused on three segments of the wound care marketplace: pharmaceutical wound care, advanced wound care and traditional wound care products. pharmaceutical wound care, advanced specialty medical device/pharmaceutical company with a primary focus on wound care. The Company has one pharmaceutical wound care product candidate that has completed a Phase 2 study and is working towards initiation of a Phase 3 study in 2012. The majority of its products are sold through distributors to various health care providers such as wound care centers, extended care facilities, acute care facilities, home health care agencies and physicians� offices. Some of its products are sold through retail channels. Effective September 4, 2013, Derma Sciences Inc acquired a 7.3% stake in Comvita Ltd, a manufacturer and wholesaler of natural health products.